Software Packages Can Make April 15 Deadline Less Taxing

For years, the bold entrepreneurs who built the personal computer industry have envisaged - even promised - a day when we'd see a PC on every desk in every workplace, every home. It hasn't happened yet, of course; the general population of the United States is far from being on-line. Scientists can't be blamed for this, however. Indeed, given its density of PCs, the science community probably ranks right up there with banking and a few other commercial sectors as contributing most to the fulfi

Written byBarry Simon
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

For years, the bold entrepreneurs who built the personal computer industry have envisaged - even promised - a day when we'd see a PC on every desk in every workplace, every home. It hasn't happened yet, of course; the general population of the United States is far from being on-line.

Scientists can't be blamed for this, however. Indeed, given its density of PCs, the science community probably ranks right up there with banking and a few other commercial sectors as contributing most to the fulfillment of the one person/one machine dream.

Most scientists have personal computers of some kind in their homes as well as their labs and offices; they've welcomed these machines as powerful tools that greatly facilitate a wide range of tasks, pertaining not only to the gathering and manipulation of research data, but also to writing papers and a host of administrative chores, such as the tracking ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies